Keverprazan is a potassium-competitive acid blocker and a novel proton pump inhibitor used primarily to treat acid-related disorders such as gastroesophageal reflux disease and gastric ulcers. This category… Read more

Keverprazan is a potassium-competitive acid blocker and a novel proton pump inhibitor used primarily to treat acid-related disorders such as gastroesophageal reflux disease and gastric ulcers. This category provides essential analytical tools for pharmaceutical research, including Keverprazan reference standards, identified impurities, and relevant metabolites. Analytical laboratories require these high-quality compounds for comprehensive impurity profiling, method validation, and stability testing of the active pharmaceutical ingredient. By utilizing these materials, researchers can accurately monitor the presence of degradation products, synthesis-related impurities, and potential genotoxic substances like nitroso-related byproducts during manufacturing and quality control processes. Accessing reliable, well-characterized reference materials is critical for ensuring compliance with regulatory standards and maintaining the safety and efficacy of the final therapeutic product throughout its lifecycle.